Table 3.

Summary of the questionnaire score at baseline.

		Mean	(SD)	(IQR)	(IQR)ref1
Global health status/QoL	QL	49.40	23.80	33.0–67.0	41.7–66.7
Physical functioning	PF	58.92	24.67	40.0–80.0	46.7–86.7
Role functioning	RF	48.48	32.53	17.0–67.0	33.3–83.3.
Emotional functioning	EF	54.80	27.34	33.0–75.0	50–83.3
Cognitive functioning	CF	74.08	24.05	67.0–100.0	66.7–100
Social functioning	SF	53.64	33.05	33.0–83.0	50–100
Fatigue	FA	56.46	29.48	33.0–78.0	22.2–66.7
Nausea and vomiting	NV	14.57	21.99	0–25.0	0–16.7
Pain	PA	36.59	33.69	0–58.5	0–66.7
Dyspnoea	DY	59.78	36.22	33.0–100.0	0–66.7
Insomnia	SL	43.72	35.22	0–67.0	0–66.7
Appetite loss	AP	40.97	37.44	0–67.0	0–66.7
Constipation	CO	27.94	36.43	0–50.0	0–33.3
Diarrhoea	DI	15.67	28.95	0–33.0	0–0
Financial difficulties	FI	29.10	33.89	0–50.0	0–33.3

Summary of the 15 scale scores of the EORTC QLQ-C30 questionnaire at baseline for all-stage lung cancer patients (n = 87) and comparison to EORTC QLQ-C30 reference values for lung cancer. ¹Reference values provided by the EORTC Quality of Life Group Members and others of the QLQ-C30 [15]. QOL, quality of life; SD, standard deviation; IQR, interquartile range.